INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

Alkermes plc.

ALKSCIK 0001520262

EDGAR filingsOpen in network
Price$45.90
1 year+47.7%
Disclosed transactions10
Buys / sells2 / 0
Max Insider Score32
Connections with evidence17

ALKS · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
Gilbert Ray Cisneros, Jr.DSelf
ALKSAlkermes plc.
Purchase
BUY$1,001 – $15KSep 29, 2026

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Connected organizationevidence
    ALKERMES, INC. POLITICAL ACTION COMMITTEEFEC Form 1 connected organization: ALKERMES, INC. (exact legal-name match) · Nov 4, 2026
  • ← Insider ofevidence
    Gaffin David JosephOfficer · Form 144 · Nov 2, 2026
  • ← Insider ofevidence
    Reed JoshuaSVP, Chief Financial Officer · Oct 9, 2026
  • ← Insider ofevidence
Oct 12, 2026
traded Sep 29, 2026
+13d
HOUSE PTR

Evidence

9
RJ
Reed JoshuaSVP, Chief Financial Officer
ALKSAlkermes plc.
Option exercise
M—
9,164 sh
Oct 8, 2026Oct 9, 2026
traded Oct 8, 2026
+1dSEC FORM 4

Evidence

21
RJ
Reed JoshuaSVP, Chief Financial Officer
ALKSAlkermes plc.
Option exercise
M—
9,164 sh
Oct 8, 2026Oct 9, 2026
traded Oct 8, 2026
+1dSEC FORM 4

Evidence

24
RJ
Reed JoshuaSVP, Chief Financial Officer
ALKSAlkermes plc.
Tax withholding
F$163K
4,069 sh
Oct 8, 2026Oct 9, 2026
traded Oct 8, 2026
+1dSEC FORM 4

Evidence

9
WC
Whitaker Anne ClemDirector
ALKSAlkermes plc.
Grant or award
A—
7,239 sh
Oct 7, 2026Oct 9, 2026
traded Oct 7, 2026
+2dSEC FORM 4

Evidence

9
WC
Whitaker Anne ClemDirector
ALKSAlkermes plc.
Grant or award
A—
18.0K sh
Oct 7, 2026Oct 9, 2026
traded Oct 7, 2026
+2dSEC FORM 4

Evidence

32
Gilbert Ray Cisneros, Jr.DSelf
ALKSAlkermes plc.
Purchase
BUY$15K – $50KJul 30, 2026Sep 4, 2026
traded Jul 30, 2026
+36dHOUSE PTR

Evidence

21
LN
Lurker NancyDirector
ALKSAlkermes plc.
Option exercise
M—
3,751 sh
Apr 11, 2026Apr 13, 2026
traded Apr 11, 2026
+2dSEC FORM 4

Evidence

13
LN
Lurker NancyDirector
ALKSAlkermes plc.
Tax withholding
F$30K
901 sh
Apr 11, 2026Apr 13, 2026
traded Apr 11, 2026
+2dSEC FORM 4

Evidence

17
LN
Lurker NancyDirector
ALKSAlkermes plc.
Option exercise
M—
3,751 sh
Apr 11, 2026Apr 13, 2026
traded Apr 11, 2026
+2dSEC FORM 4

Evidence

Whitaker Anne Clem
Director · Oct 9, 2026
  • ← Disclosed trade inevidence
    Gilbert Ray Cisneros, Jr.Purchase disclosed 2026-09-04 · Sep 4, 2026
  • ← Lobbied forevidence
    MONUMENT ADVOCACYLDA RR 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    THORN RUN PARTNERSLDA Q1 2026 first quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    PENN AVENUE PARTNERSLDA Q2 2026 second quarter · Pharmacy · Aug 26, 2026
  • ← Lobbied forevidence
    SPLITOAK STRATEGIES LLCLDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    S-3 GROUPLDA Q2 2026 second quarter · ALC · Aug 26, 2026
  • ← Lobbied forevidence
    BGR GOVERNMENT AFFAIRSLDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    CROSSROADS STRATEGIES, LLCLDA RA 2026 first quarter · Pharmacy · Aug 26, 2026
  • ← Lobbied forevidence
    LMH STRATEGIC SOLUTIONSLDA Q1 2026 first quarter · Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    BALLARD PARTNERSLDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    TODD STRATEGY GROUPLDA Q2 2026 second quarter · Health issues · Aug 26, 2026
  • ← Insider ofevidence
    Lurker NancyDirector · Apr 13, 2026
  • Planned sales and 5% stakes

    Form 144, 13D and 13G
    • GJGaffin David JosephOfficer · sale around Nov 3, 2026 · 2,035 shares · 10b5-1 plan$94KForm 144 · filed Nov 3, 2026

    Lobbying

    $1.96M reported · de-duplicated
    2026 Q2 $930K in-house2026 Q1 $1.03M in-house
    • CROSSROADS STRATEGIES, LLC$50K2026 Q1 · posted Aug 26, 2026 · Pharmacy
    • S-3 GROUP$80K2026 Q1 · posted Aug 26, 2026 · ALC
    • SPLITOAK STRATEGIES LLC$60K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid
    • CROSSROADS STRATEGIES, LLC$60K2026 Q2 · posted Aug 26, 2026 · Pharmacy
    • THORN RUN PARTNERS$90K2026 Q2 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid
    • LMH STRATEGIC SOLUTIONS$60K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid
    • In-house report$930K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues, ALC, TAR
    • In-house report$1.03M2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues, ALC, TAR
    • THORN RUN PARTNERS$60K2026 Q1 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid
    • LMH STRATEGIC SOLUTIONS$60K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid
    • PENN AVENUE PARTNERS$80K2026 Q1 · posted Aug 26, 2026 · Pharmacy
    • CROSSROADS STRATEGIES, LLC—2026 Q1 · posted Aug 26, 2026 · Pharmacy

    Connected PAC contributions

    FEC · direct to members
    • Brett GuthrieR$10KALKERMES, INC. POLITICAL ACTION COMMITTEE
    • Michael A. RulliR$10KALKERMES, INC. POLITICAL ACTION COMMITTEE
    • Aaron BeanR$10KALKERMES, INC. POLITICAL ACTION COMMITTEE
    • Katherine M. ClarkD$5,000ALKERMES, INC. POLITICAL ACTION COMMITTEE
    • Jon HustedR$5,000ALKERMES, INC. POLITICAL ACTION COMMITTEE
    Mike CareyR
    $5,000
    ALKERMES, INC. POLITICAL ACTION COMMITTEE
  • Neal P. DunnR$5,000ALKERMES, INC. POLITICAL ACTION COMMITTEE
  • Bill CassidyR$3,500ALKERMES, INC. POLITICAL ACTION COMMITTEE
  • Josh GottheimerD$2,500ALKERMES, INC. POLITICAL ACTION COMMITTEE
  • Donald G. DavisD$2,500ALKERMES, INC. POLITICAL ACTION COMMITTEE
  • Suzan K. DelBeneD$2,500ALKERMES, INC. POLITICAL ACTION COMMITTEE
  • Ashley MoodyR$2,500ALKERMES, INC. POLITICAL ACTION COMMITTEE